Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...
Royal Philips, together with Erasmus MC and a broad consortium of industry, academic, and patient partners, has secured funding from the EU’s Innovative Health Initiative to coordinate the five-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results